From Surf Wiki (app.surf) — the open knowledge base
Ublituximab
Ublituximab, sold under the brand name Briumvi, is an immunomodulator used for the treatment of multiple sclerosis. It is a CD20-directed cytolytic monoclonal antibody.
Rendering article…
Content sourced from manual.
This content may have been generated or modified by AI, and may be sourced from third parties. CloudSurf Software LLC makes no warranties as to its accuracy, completeness, or reliability, and accepts no liability for it. Always verify important information against primary sources.
Report